$VEEV

Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock Up

Veeva Systems (VEEV) reported Q2 fiscal 2027 adjusted EPS of $2.35, up 18.1% YoY, and revenues of $928M, up 17.6% YoY, both beating estimates. The company raised its full-year guidance and saw strong growth in subscriptions and services. Shares rose over 9% in after-market trading. VEEV's cash position was $7.24B at quarter-end.

Original reporting
Published Aug 27, 2026, 5:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 4:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock Up — source image
Decision brief

The 30-second read

$VEEVBullishHigh
01

Why it matters

Earnings beat and guidance raise are likely to drive short‑term price appreciation.

02

Market read

First report of earnings and guidance for a large‑cap SaaS firm; high trading relevance.

03

What to watch

Potential slowdown in AI adoption or competitive pressure from larger cloud providers.

Relevance 8/10Novelty 8/10Timing: after‑hours today

Background

Veeva Systems reported Q2 FY27 results, beating consensus and raising FY guidance.

Company-level read

Ticker impact

$VEEVBullishHigh confidence
Context

Q2 earnings beat estimates and FY27 guidance raised, with 9% after‑hours price jump.

Expected impact

Potential further 5‑10% rally in the next few days as investors digest the beat and guidance lift.

Evidence & confidence

Earnings beat, revenue growth, and guidance raise are primary catalysts for a mid‑cap stock; market already reacted positively.

Market effects

Boosts outlook for cloud‑based life‑science software sector, may lift peers.

Positive for US tech and biotech equities.

Limited to investors tracking SaaS and life‑science software markets.

Counterpoint

Guidance may be overly optimistic; execution risk could temper upside.

Key entities

  • Veeva Systems

    Provider of cloud‑based software for life‑science industry.

Related articles

$VEEVHighAI 9/10

Why Veeva Systems Stock Is Soaring This Week

Veeva Systems (VEEV) stock rose 13.8% after its Q2 fiscal 2027 earnings beat estimates, with adjusted EPS of $2.35 on revenue of $928M, up 18% YoY. The company also raised its full-year guidance above analyst expectations.

$VEEVHighAI 9/10

VEEV Looks 3.7% Undervalued on GF Value™

Veeva Systems (VEEV) shares rose 15% to $282.13 after strong quarterly results and raised fiscal 2027 revenue guidance. GF Value™ estimates VEEV is 3.7% undervalued with a GF Score™ of 90/100. Subscription revenue grew 16% YoY to $766.8M, and the company projects $3.68B-$3.69B in revenue for 2027.

$VEEVHighAI 8/10

[Veeva Systems Q2 2027 Earnings Call] Veeva Rides Record CRM Quarter and Falcon AI Buzz to $928M Revenue, Up 13% — BigGo Finance

Veeva Systems reported $928M in Q2 2027 revenue, up 13% YoY, with non-GAAP operating income of $416M, exceeding guidance. CEO Peter Gassner highlighted record CRM performance and strong momentum for AI product Falcon. The company raised full-year guidance, citing broad-based commercial strength and strategic product transitions in R&D. Vault CRM gained adoption among top biopharma companies, and Falcon saw high early interest. Aspen, a horizontal CRM startup within Veeva, was noted for its simpl